Stay updated with breaking news from Seth Lederman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
What do sports medicine and business franchises have in common? Seth Lederman. He’s been in both businesses and helping people find their perfect franchise (or turning their successful business into a franchise) is what really gets him out of bed in the morning. “I was a successful spine and sports medicine physician. As you know, […]
The study did not achieve statistical significance on the primary endpoint Tonix is discontinuing development of TNX-601 ER based on the efficacy results...
30.10.2023 - Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General Hospital TNX-1500 is currently in Phase 1 Clinical Development Tonix is Developing TNX-1500 for Prevention of Kidney Allograft Rejection as the First ... Seite 1
Tonix Pharmaceuticals (NASDAQ:TNXP) said it expects to receive the topline results from its 88-patient Phase 2 PREVENTION study of its investigational drug...